Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 16:14:319.
doi: 10.1186/s12936-015-0838-5.

Elimination of Plasmodium falciparum in an area of multi-drug resistance

Affiliations

Elimination of Plasmodium falciparum in an area of multi-drug resistance

Khin Maung Lwin et al. Malar J. .

Abstract

Background: Resistance to the artemisinin derivatives in Plasmodium falciparum has emerged in Cambodia and is now spreading throughout South-East Asia. The rapid elimination of P. falciparum seems to be the only viable option to avoid a public health disaster but this is difficult because even in low transmission settings many residents have asymptomatic parasitaemias.

Methods: In response to a large number of malaria cases reported in three remote villages on the Thai-Myanmar border where malaria is endemic and the disease is seasonal, surveys were conducted using an ultra-sensitive qPCR assay (LOD 22 parasites per mL). In one of the villages where it was feasible, mass anti-malarial drug administration was proposed to the population as a potential solution, and this was adopted.

Results: In the three villages 204/356 (57.3 %), 212/385 (55.1 %) and 195/286 (68.2 %) of the resident populations were positive by qPCR (approximately one-third P. falciparum and two-thirds P. vivax). Of those positive for P. falciparum 62 % carried single point mutations in the P. falciparum kelch protein (a marker of artemisinin resistance). In one of the villages 217 of 674 inhabitants received at least one dose of dihydroartemisinin-piperaquine chemoprevention in June 2012, 155 (71.4 %) received two consecutive months, and 98 (45.2 %) received three treatment doses. The chemoprevention was generally well tolerated. The sub-microscopic reservoir of P. falciparum malaria was eliminated during the six-month follow-up period (prevalence fell from 7 to 0 %); P. vivax malaria persisted (prevalence fell from 35 to 8 %). From June to October 2012 (rainy season) the number of clinical episodes of P. falciparum was six times lower (46), than during the same period in the previous year (290).

Conclusion: Mass drug administration with dihydroartemisinin-piperaquine may be an effective strategy to eliminate P. falciparum rapidly where multi-drug resistance is present.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Prevalence of malaria by species in the three villages. The upper panel shows the distribution of the species: black: P. falciparum, orange: P. vivax, green: mixed infections. The lower panel shows the prevalence of malaria in the three villages. Blue: microscopy, and Green: qPCR.
Fig. 2
Fig. 2
Prevalence of malaria in the 96 participants who received the full course of DP. Blue: P. falciparum, Red: P. vivax, Green: indeterminate species.

References

    1. WHO . World malaria report. Geneva: World Health Organization; 2012.
    1. WHO . Global plan for artemisinin resistance containment. Geneva: World Health Organization; 2012.
    1. WHO . Emergency response plan to artemisinin resistance in the Greater Mekong Subregion. Geneva: World Health Organization; 2013.
    1. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411–423. doi: 10.1056/NEJMoa1314981. - DOI - PMC - PubMed
    1. Carrara VI, Lwin KM, Phyo AP, Ashley E, Wiladphaingern J, Sriprawat K, et al. Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999–2011: an observational study. PLoS Med. 2013;10:e1001398. doi: 10.1371/journal.pmed.1001398. - DOI - PMC - PubMed

LinkOut - more resources